Vivimed Labs Limited (NSE:VIVIMEDLAB)

India · Delayed Price · Currency is INR

5.55

-0.29 (-4.97%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Speciality Chemicals Business	-	58.98M	112.21M	412.04M	535.09M
Speciality Chemicals Business Growth	-	-47.44%	-72.77%	-23.00%	-47.05%
Pharma Business	1.16B	1.43B	1.77B	1.96B	8.08B
Pharma Business Growth	-18.79%	-19.04%	-9.81%	-75.73%	-15.64%
Total	1.16B	1.49B	1.88B	2.37B	8.61B
Total Growth	-22.00%	-20.74%	-20.74%	-72.46%	-18.64%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	908.21M	1.41B	1.68B	2.31B	3.20B
India Growth	-35.42%	-16.28%	-27.20%	-27.81%	32.51%
Export	254.48M	84.32M	191.13M	58.20M	5.22B
Export Growth	201.80%	-55.88%	228.40%	-98.88%	-30.11%
Unallocated	-	-	-	7.17M	202.48M
Unallocated Growth	-	-	-	-96.46%	-71.59%
Total	1.16B	1.49B	1.87B	2.37B	8.61B
Total Growth	-22.00%	-20.33%	-21.15%	-72.46%	-18.64%

Source: S&P Global Market Intelligence.